Xtx Topco LTD Alaunos Therapeutics, Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.04 - $322.5 $24,672 - $7.65 Million	23,724 New	23,724 $41,000
Q1 2022 May 13, 2022	SELL	$0.62 - $1.17 $27,386 - $51,681	-44,172 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.09 - $1.89 $48,147 - $83,485	44,172 New	44,172 $48,000
Q3 2021 Nov 12, 2021	SELL	$1.44 - $2.73 $69,049 - $130,906	-47,951 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$2.63 - $3.67 $74,373 - $103,783	28,279 Added 143.75%	47,951 $127,000
Q1 2021 May 14, 2021	BUY	$2.82 - $5.6 $55,475 - $110,163	19,672 New	19,672 $71,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.